These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1651031)

  • 1. [A new imaging procedure for detecting endocrine tumors].
    Schäffer M; Fölsch UR
    Z Gastroenterol; 1991 Apr; 29(4):173-4. PubMed ID: 1651031
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatostatin-receptor imaging for the detection of tumors.
    Patel YC
    N Engl J Med; 1990 Nov; 323(18):1274-6. PubMed ID: 2170841
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs.
    Lamberts SW; Bakker WH; Reubi JC; Krenning EP
    Metabolism; 1990 Sep; 39(9 Suppl 2):152-5. PubMed ID: 2169572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
    Weinel RJ; Kisker O; Joseph K; Welcke U; Zaraca F; Rothmund M
    Chirurg; 1994 Oct; 65(10):849-55. PubMed ID: 7821043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin-receptor imaging in the localization of endocrine tumors.
    Lamberts SW; Bakker WH; Reubi JC; Krenning EP
    N Engl J Med; 1990 Nov; 323(18):1246-9. PubMed ID: 2170840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 111In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-entero-pancreatic tumors.
    Nauck C; Ivancević V; Emrich D; Creutzfeldt W
    Z Gastroenterol; 1994 Jun; 32(6):323-7. PubMed ID: 7975760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo somatostatin receptor imaging in the detection and treatment of gastrointestinal cancer.
    Schubert ML
    Gastroenterology; 1991 Apr; 100(4):1143-4. PubMed ID: 1848196
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas.
    Schmidt M; Fischer E; Dietlein M; Michel O; Weber K; Moka D; Stennert E; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1571-80. PubMed ID: 12458390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Receptor scintigraphy with somatostatin analog in oncology].
    Krenning EP; Bakker WH; Lamberts SW
    Ned Tijdschr Geneeskd; 1990 Jun; 134(22):1077-80. PubMed ID: 1972265
    [No Abstract]   [Full Text] [Related]  

  • 10. [Somatostatin receptor scintigraphy. Methodology, indications, results].
    Eising EG; Bier D; Knust EJ; Reiners C
    Radiologe; 1996 Jan; 36(1):81-8. PubMed ID: 8820376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
    Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
    [No Abstract]   [Full Text] [Related]  

  • 12. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
    Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
    J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide.
    Forssell-Aronsson E; Fjälling M; Nilsson O; Tisell LE; Wängberg B; Ahlman H
    J Nucl Med; 1995 Jan; 36(1):7-12. PubMed ID: 7799086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new diagnostic method: somatostatin receptor scintigraphy of neuroendocrine tumors].
    Westlin JE; Janson ET; Ahlström H; Ohrvall U; Arnberg H; Nilsson S; Akerström G; Oberg K
    Lakartidningen; 1992 Dec; 89(50):4377-9. PubMed ID: 1469974
    [No Abstract]   [Full Text] [Related]  

  • 15. Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy.
    Ohrvall U; Westlin JE; Nilsson S; Juhlin C; Rastad J; Lundqvist H; Akerström G
    Cancer; 1997 Dec; 80(12 Suppl):2490-4. PubMed ID: 9406700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Indium-111 octreotide scintigraphy and low-dose computed tomography in localization of neuroendocrine tumors.
    Kjaer A; Dreyer M
    Clin Nucl Med; 2003 Jun; 28(6):506-8. PubMed ID: 12917538
    [No Abstract]   [Full Text] [Related]  

  • 17. Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.
    Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Neuhaus C; Lenze H; Trautmann ME; Arnold R
    Horm Metab Res Suppl; 1993; 27():28-35. PubMed ID: 8330869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor SPECT.
    Pepe G; Moncayo R; Bombardieri E; Chiti A
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S41-51. PubMed ID: 22388628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide.
    Nocaudie-Calzada M; Huglo D; Deveaux M; Carnaille B; Proye C; Marchandise X
    J Nucl Med; 1994 Jan; 35(1):57-62. PubMed ID: 8271061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide scintigraphy for the detection of paragangliomas.
    Kwekkeboom DJ; van Urk H; Pauw BK; Lamberts SW; Kooij PP; Hoogma RP; Krenning EP
    J Nucl Med; 1993 Jun; 34(6):873-8. PubMed ID: 8389841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.